Clinical value of dexmedetomidine anesthesia in patients with unilateral breast cancer modified radical mastectomy
Objective:To clarify the clinical anesthesia value of dexmedetomidine in patients undergoing unilateral breast cancer modified radical mastectomy.Methods:120 patients undergoing unilateral breast cancer modified radical mastectomy in our hospital were randomly divided into an observation group(n =60)and a control group(n =60)using a computer.The observation group received dexmedetomidine on top of the regular anesthesia protocol,while the control group received the regular anesthesia protocol.The clinical anesthesia effects,postoperative agitation during the recovery period,and hemodynamic indicators were compared between the two groups.Results:There was no statistical difference in the operation duration between the two groups(P＞0.05).The observation group had lower Ramsay sedation scores at 2 h and 8 h post-operation(P＜0.05),shorter postoperative recovery time and extubation time(P＜0.05),lower agitation rating scores and SAS scores(P＜0.05).Before anesthesia,there was no statistical difference in SBP,DBP,HR,and SpO2 data between the two groups(P＞0.05).During extubation,SBP,DBP,and HR in the observation group were significantly lower than those in the control group,while SpO2 was higher(P＜0.05).Conclusion:U-sing dexmedetomidine in patients undergoing unilateral breast cancer modified radical mastectomy has good an-esthesia effects,helping to reduce postoperative agitation during the recovery period and improve hemodynamic conditions.
DexmedetomidineModified radical mastectomy for unilateral breast cancerAnesthetic effectAnesthesia recovery agitationHemodynamics
NETL
NSTL
万方数据
维普
